Skip to main content
SpringerLink
Log in

Nasopharyngeal Carcinoma

  • Chapter
Book cover Immune Deficiency and Cancer

Abstract

Besides Burkitt’s lymphoma (BL) nasopharyngeal carcinoma (NPC) represents a unique model for studying the relationships between Epstein-Barr virus (EBV) infection, immune response, and neoplastic transformation. The association of EBV infection and NPC is even closer than in BL: all nonkeratinizing NPC exhibit significantly elevated anti-EBV antibody titers while extra-African BL only sporadically are seropositive.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Old, J.L., Boyse, E.A., Oettgen, H.F., de Harven, E., Geering, G., Williamson, B., and Clifford, P. Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc. Natl. Acad. Sci. (USA), 56:1699, 1966.

    CAS  Google Scholar 

  2. Henle, G. and Henle, W. Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bac t., 91:1248, 1966.

    CAS  Google Scholar 

  3. Henle, W., Henle, G., Ho, H.C., Burtin, P., Cachin, Y., Clifford, P., de Schryver, C1., de The, G., Diehl, V., and Klein, G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups. J. Natl. Cancer Inst., 44;225, 1970.

    PubMed  CAS  Google Scholar 

  4. Henle, G., Henle, W., and Klein, G. Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells. Int. J. Cancer, 8:272, 1971.

    PubMed  CAS  Google Scholar 

  5. Henie, W., Ho, H.D., Henle, G., and Kwan, H.C. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma, comparison of active cases of long terra survivors. J. Natl, Cancer Inst., 51:361, 1973.

    Google Scholar 

  6. Henle, G. and Henle, W. Epstein-Barr virus-specific IgA seruir antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer, 17:1, 1976.

    PubMed  CAS  Google Scholar 

  7. Reedman, B.M. and Klein, G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer, 11:499, 1973.

    PubMed  CAS  Google Scholar 

  8. zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Santesson, L. EB-virus DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature, 228;1056, 1970.

    PubMed  Google Scholar 

  9. Nonoyama, M., Huang, C.H., Pagano, J.S., Klein, G., and Singh, S. DNA of Epstein-Barr virus detected in tissue of Burkitt’s lymphoma and nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. (USA), 70:3265, 1973.

    CAS  Google Scholar 

  10. Andersson-Anvret, M., Forsby, N., Klein, G., and Henle, W. Studies on the occurrence of Epstein-Barr virus DNA in nasopharyngeal carcinomas, in comparison with tumors of other head and neck regions. Int. J. Cancer, 20:486, 1977.

    PubMed  CAS  Google Scholar 

  11. Wolf, H., zur Hausen, H., and Becker, V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol., 244:245, 1973.

    PubMed  CAS  Google Scholar 

  12. Wolfe, H., zur Hausen, H., Klein, G., Becker, V., Henle, G., and Henle, W. Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr virus DNA in nonlymphoid nasopharyngeal carcinoma cells. Med. Microbiol. Immunol., 161;15, 1975.

    Google Scholar 

  13. Prasad, U. Significance of metaplastic transformation in the pathogenesis of nasopharyngeal carcinoma. Clinical, histopathological, and ultrastructural studies. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 31–39. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  14. Prathap, K., Prasad, U., and Ablashi, D.V. The pathology of nasopharyngeal carcinoma in Malaysians. In: IVth Internatl. Symposium NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  15. Yin, S.Y. Study on the histogenesis of nasopharyngeal carcinoma (NPC). In: IVth Internatl. Symposium NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  16. Krueger, G.R.F. and Hirano, T. Special procedures for the differential diagnosis of nasopharyngeal carcinoma. In: IVth Internatl. Symposium NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  17. Micheau, C., Rilke, F., and Pilotti, S. Proposal for a new histopathological classification of the carcinomas of the nasopharynx. Tumori., 64:513, 1978.

    PubMed  CAS  Google Scholar 

  18. Krueger, G.R.F. and Wustrow, J. Current histological classification of nasopharyngeal carcinoma (NPC) at Cologne University. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 11–15. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  19. Krueger, G.R.F., Kottaridis, S.D., Wolf, H., Ablashi, D.V., Sesterhenn, K., and Bertram, G. Histological types of nasopharyngeal carcinoma as compared to EBV serology. Anticancer Research, 1:187, 1981.

    PubMed  CAS  Google Scholar 

  20. Costa, J. The histopathological diagnosis of nasopharyngeal carcinoma. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.). Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 7–10. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  21. Svoboda, D.J., Kirchner, F.R., and Shanmugaratnam, K. The fine structure of nasopharyngeal carcinomas. In: C.S. Muir and K. Shanmugaratnam (eds.), Cancer of the Nasopharynx. UICC Monograph Series, Vol. 1, pp. 163–171. Copenhagen: Munksgaard, 1967.

    Google Scholar 

  22. Perez, C.A., Ackerman, L.V., Mill, W.B., Ogura, J.H., and Powers, W.E. Cancer of the nasopharynx: factors influencing prognosis. Cancer, 24: 1, 1969.

    PubMed  CAS  Google Scholar 

  23. Gazzolo, L., de The, G., Vuillaume, M., and Ho, H.C. Nasopharyngeal carcinoma. II. Ultrastructure of normal mucosa, tumor biopsies, and subsequent epithelial growth in vitro. J. Natl. Cancer Inst., 48(1):73, 1972.

    PubMed  CAS  Google Scholar 

  24. Sesterhenn, J., Sesterhenn, K., Hyams, V., Krueger, G.R.F., and Langloos, B.G. Demonstration of keratin-antigens in undifferentiated carcinomas of the nasopharyngeal type and malignant lymphomas — a contribution ot practical differential diagnosis. In: IVth Internatl. Symposium NPC. Kuala Lumpur, Malaysia, 1982, in print.

    Google Scholar 

  25. Wustrow, J., Karpinski, A., Haas, W., Krueger, G.R.F., Bertram, G., and Sesterhenn, K. Correlation of histological NPC tumor types with local and peripheral T-and B-cell values. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 193–199. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  26. Jondal, M. and Klein, G. Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies. Biomedicine, 23:163, 1975.

    PubMed  CAS  Google Scholar 

  27. de The, G., Ho, H.C., Kwan, H.C., Desgranges, C., and Favre, M.C Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation. Int. J. Cancer, 6:189, 1970.

    Google Scholar 

  28. Klein, G., Giovanella, B.C., Lindahl, T., Fialkow, P.J., Singh, S., and Stehlin, J. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. (USA), 71:4737, 1974.

    CAS  Google Scholar 

  29. Wustrow, J. personal communication, 1980.

    Google Scholar 

  30. Shanmugaratnam, K., Cahn, S.H., de Thé, G., Goh, J.E.H., Khor, T.H., Simons, M.J., and Tye, C.Y. Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology survival rates and other biological characteristics. Cancer, 44:1029, 1979.

    PubMed  CAS  Google Scholar 

  31. Weiland, L. Clinical pathology: current status. In: IVth Intematl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  32. Waterhouse, J., Muir, C., Correa, P., and Powell, J. (eds.). Cancer Incidence in Five Continents. IARC Scientific Publ. Vol. III, No. 15. Lyon, 1976.

    Google Scholar 

  33. Nielsen, N.H., Mikkelsen, F., and Hart-Hansen, J.P. Nasopharyngeal cancer in Greenland. The incidence in an Artic Eskimo population. Acta Path. Microbiol. Scand. Sect. A., 85:850, 1977.

    CAS  Google Scholar 

  34. Blot, W.J., Lanier, A., Fraumeni, J.F., and Bender, T.R. Cancer mortality among Alaskan natives, 1960–1969. J. Natl. Cancer Inst., 55:547, 1975.

    PubMed  CAS  Google Scholar 

  35. Mallen, R.W. and Shandro, W.G. Nasopharyngeal carcinoma in Eskimos. Canad. J. Otolaryng., 3:175, 1974.

    CAS  Google Scholar 

  36. Schaefer, J., Hildes, J.A., Medd, L.M., and Cameron, D.G. The changing pattern of neoplastic disease in Canadian Eskimos. Canad. Med. Ass., 112:1399, 1975.

    CAS  Google Scholar 

  37. Krueger, J., Ieromnimon, V., and Dahr, W. Frequencies of HLA antigens in patients with NPC. In: E. Grundraann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 201–203. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  38. Klein, G. The Epstein-Barr virus. In: A.S. Kaplan (ed.), The Herpesviruses. pp. 521–555. New York: Academic Press, 1973.

    Google Scholar 

  39. de Thé, G. Role of Epstein-Barr virus in human diseases: infectious mononucleosis, Burkitt’s lymphoma, and nasopharyngeal carcinoma. In: G. Klein (ed.), Viral Oncology, pp. 769–797. New York: Raven Press, 1980.

    Google Scholar 

  40. Henle, W. and Henle, G. The association of Epstein-Barr virus with nasopharyngeal carcinoma. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 1–6. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  41. Levine, P.H., Wallen, W.C., Ablashi, D.V., Granlund, D.J., and Connelly, R. Comparative studies on immunity to EBV-associated antigens in NPC patients in North America, Tunisia, France and Hong Kong. Int. J. Cancer, 20:332, 1977.

    PubMed  CAS  Google Scholar 

  42. Levine, P.H., Lamelin, J.P., and Stevens, D.A. Cell mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma. In: G. de The and Y. Ito (eds.), Nasopharyngeal Carcinoma: Etiology and Control. Vol. 20, pp. 483–494. Lyon: IARC Publ., 1978.

    Google Scholar 

  43. Ablashi, D.V., Easton, J.M., Levine, P.H., Krueger, G.R.F., and Connelly, R. Immunological comparison of nasopharyngeal carcinoma and Burkitt’s lymphoma from relatively high and low-risk populations. In: L. Severi (ed.), Tumours of Early Life in Man and Animals. VIth Perugia Quadrennial International Conference on Cancer, pp. 195–210. Preugia, Italy, 1977.

    Google Scholar 

  44. Ebbesen, P., Levine, P.H., Connelly, R., Walker, S., and Mestre, M. Case-control study of antibodies to Epstein-Barr viral capsid antigen and early antigen in Greenland Eskimos and Caucasian controls living in Greenland and Denmark. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.)., Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 119–123. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  45. Armstrong, G.R., Ablashi, D.V., Pearson, G.R., Krueger, G., Easton, J.M., Bouguermouth, A., Allai, L., Prasad, U., and Connelly, R. Comparison of Epstein-Barr virus antigens in nasopharyngeal carcinoma from intermediate and low risk populations. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 169–178. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  46. Ho, U.C., Lau, W.H., Kwan, H.C., Chan, C.L., Au, G.K.H., Saw, D., and de Thé, G. Diagnostic and prognostic serological markers in nasopharyngeal carcinoma (NPC). In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 219–224. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  47. Levine, P.H., Chan, S.H., Terasaki, P., and Hewetson, J. Studies on HLA antigens and EBV antibodies: implications for the prevention of nasopharyngeal carcinoma. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5 pp. 247–253. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  48. Joncas, J., Seeley, J., Purtilo, D.T., Ghibu, F.M., Lichaa, H., Robillard, L., Alfieri, C., Rioux, E., and Montplatsir, S. Immunological defect in a family with multiple nasopharyngeal carcinoma (NPC) and Burkitt’s lymphoma (BL). In: D. Yohn (ed.), Comparative Leukemia and Related Diseases, pp. 561–562. New York: Elsevier North-Holland, 1982.

    Google Scholar 

  49. de The, G., Day, N.E., Geser, A. et al. Seroepidemiology of the Epstein-Barr virus: preliminary analysis of an international study — a review. In: G. de The, M.A. Epstein and H. zur Hausen (eds.), Oncogenesis and Herpesviruses. Part 2, pp. 3–16. II. Internatl. Agency for Research on Cancer, Lyon, 1975.

    Google Scholar 

  50. Henle, G., Henle, W., and Klein, G. Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells. Int. J. Cancer, 8: 272, 1971.

    PubMed  CAS  Google Scholar 

  51. Pearson, G.R. Epstein-Barr virus: immunology. In: G. Klein (ed.), Viral Oncology, pp. 739–767. New York: Raven Press, 1980.

    Google Scholar 

  52. Kieff, E., Dambaugh, T., Heller, M., King, W., van Santen, V., and Cheung, A. Structure and function of the Epstein-Barr virus genome: a brief overview. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5 pp. 87–94. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  53. Kieff, E. Virology: current status. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  54. Bornkamm, G.W. and Desgranges, C. The Epstein-Barr virus genome: structural organization and its detection in nasopharyngeal carcinoma. In: Actualites carcinoloquques. Institut Gustave-Roussy. “Cancer du naso-pharynx.” Paris, 1982.

    Google Scholar 

  55. Adams, A. Molecular biology of the Epstein-Barr virus. In: G. Klein (ed.), Viral Oncology, pp. 683–711. New York: Raven Press, 1980.

    Google Scholar 

  56. Haas, W., Krueger, G.R.F., and Vix, M. Further attempts to search for retrovirus related antigens in nasopharyngeal carcinomas and in other neoplasms. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia in print, 1982.

    Google Scholar 

  57. Lindahl, T., Klein, G., Reedman, B.M., Johansson, B., and Singh, S. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int. J. Cancer, 13:764, 1974.

    PubMed  CAS  Google Scholar 

  58. Epstein, A.L., Henle, W., Henle, G., Hewetson, J.F., and Kaplan, H.S. Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt’s lymphoma cell lines. Proc. Natl. Acad. Sci. (USA), 73:228, 1976.

    CAS  Google Scholar 

  59. Andersson, M. and Lindahl, T. Epstein-Barr virus DNA in human lymphoid cell lines: in vitro conversion. Virology, 73:96, 1976.

    PubMed  CAS  Google Scholar 

  60. Klein, G., Giovanella, B., Westman, A., Stehlin, J.S., and Muraford, D. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics, EBV-infectibility, and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology, 5:319, 1974.

    Google Scholar 

  61. Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menezes, J., Nilsson, K., and Sundstrom, C. Continuous lymphoid cell lines with characteristics of B-cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc. Natl. Acad. Sci. USA, 71:3283, 1974.

    PubMed  CAS  Google Scholar 

  62. Steinitz, M. and Klein, G. Comparison between growth characteristics of an Epstein-Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro. Proc. Natl. Acad. Sci. USA, 72:3518, 1975.

    PubMed  CAS  Google Scholar 

  63. Steinitz, M. and Klein, G. Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established EBV-negative lymphoma lines in vitro. Virology, 70: 570, 1976.

    PubMed  CAS  Google Scholar 

  64. Andersson-Anvret, M. and Lindahl, T. Integrated viral DNA sequences in EB virus-converted human lymphoma lines. J. Virol. 25:710, 1978.

    PubMed  CAS  Google Scholar 

  65. Trumper, P.A., Epstein, M.A., Giovanella, B.C., and Finerty, S. Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma. Int. J. Cancer, 20:655, 1977.

    PubMed  CAS  Google Scholar 

  66. Viral Oncology. G. Klein (ed.). New York: Raven Press, 1930.

    Google Scholar 

  67. The Epstein-Barr Virus. M.A. Epstein, and B.G. Achong (eds.). Berlin-Heidelberg-New York: Springer-Verlag, 1979.

    Google Scholar 

  68. Greaves, M.F., Owen, J.J., and Raff, M.C. T- and B-lymphocytes: properties and roles in immune response. Excerpta Medica Amsterdam, 1973.

    Google Scholar 

  69. Jondal, M. and Klein, G. Surface markers on human B- and T-lymphocytes. II. Presence of Epstein-Barr virus receptors on B-lymphocytes. J. Exp. Med., 138:1365, 1973.

    PubMed  CAS  Google Scholar 

  70. Klein, G., Yefenof, E., Falk, K., and Westman, A. Relationship between Epstein-Barr virus (EBV)-production and the loss of EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt’s lymphoma. Int. J. Cancer, 21: 552, 1978.

    PubMed  CAS  Google Scholar 

  71. Einhorn, L., Steinitz, M., Yefenof, E., Ernberg, I., Bakacs, T., and Klein, G. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV-infectivity of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Cell. Immunol., 35:43, 1978.

    PubMed  CAS  Google Scholar 

  72. Orr, H., Fuks, A., Kaufmann, J. Lancet, D. et al. Structural studies of the membrane associated products of the human major histocompatibility complex. In; C.M. Fenoglio and D.W. King (eds.), Advances in Pathobiology: Cell Membranes. New York: Intercontinental Medical Book, 1978.

    Google Scholar 

  73. Strominger, J.L. and Thorley-Lawson, D. Early events in transformation of human lymphocytes by the virus. In: M.A. Epstein and B.G. Achong (eds.), The Epstein-Barr virus. Chapter 9. Berlin-Heidelberg-New York: Springer Verlag, 1979.

    Google Scholar 

  74. Wolf, H., Bayliss, G.J., and Wilmes, E. Biological properties of Epstein-Barr virus. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5 pp. 101–109. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  75. Pope, J.H. Transformation by the virus in vitro. In: M.A. Epstein, and B.G. Achong (eds.), The Epstein-Barr Virus. Chapter 10. Berlin-Heidelberg-New York: Springer Verlag, 1979.

    Google Scholar 

  76. Huang, D.P., Ho, H.C., Ng, M.H., and Lui, M. Possible transformation of nasopharyngeal epithelial cells in culture with Epstein-Barr virus from B985–8 cells. Br. J. Cancer, 35:630, 1977.

    PubMed  CAS  Google Scholar 

  77. Volsky, D.J., Shapiro, I.M., and Klein, G. Transfer of Epstein-Barr virus receptors to receptor-negative cell permits virus penetration and antigen expression. Proc. Natl. Acad. Sci. USA, 77:9:5453, 1980.

    PubMed  CAS  Google Scholar 

  78. Volsky, D.J., Klein, G., Volsky, B., and Shapiro, I.M. Production of infectious Epstein-Barr virus in mouse lymphocytes. Nature, 293; 5831:399, 1981.

    PubMed  CAS  Google Scholar 

  79. Lenoir, G. and de The, G. Epstein-Barr virus epithelial cell interaction and its implication in the etiology of nasopharyngeal carcinoma. In: G. de The, and Y. Ito (eds.), Nasopharyngeal Carcinoma: Etiology and Control. p. 377. Lyon: IARC.

    Google Scholar 

  80. Volsky, D.J. and Shapiro, I.M. Infection of normal human epithelial cells by Epstein-Barr virus (EBV) following transplantation of EBV receptors onto epithelial cell surface. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  81. Glaser, R. The infection of epithelial cells with Epstein-Barr virus. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  82. Khelifa, R. and Menezes, J. A model study of Epstein-Barr virus (EBV) penetration into EBV receptor-negative cells. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  83. Pagano, J.S., Raab-Traub, N., Feighny, R., and Pearson, G. EBV expression in nasopharyngeal carcinoma. In: IVth Internatl Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  84. Collett, M.S. and Erikson, R.L. Protein kinase activity associated with the avian sarcoma virus src gene product. Proc. Natl. Acad. Sci. USA, 75:4:2021, 1978.

    PubMed  CAS  Google Scholar 

  85. Sen, A. and Todaro, G.J. A murine sarcoma virus-associated protein kinase: interaction with actin and microtubular protein. Cell., 17:347, 1979.

    PubMed  CAS  Google Scholar 

  86. Barnekow, A., Boschek, B.C., Ziemiecki, A., and Bauer, H. Detection of src-gene product pp60 and its associated protein kinase on the surface of Rouse-sarcoma-virus-transformed cells. Viochem. Soc. Trans., 8:735, 1980.

    CAS  Google Scholar 

  87. Erikson, E. and Erikson, R.L. Identification of a cellular protein substrate phosphorylated by the Avian sarcoma virus-transforming gene product. Cell., 21:829, 1980.

    PubMed  CAS  Google Scholar 

  88. Hunter, T. and Sefton, B.M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77:3:1311, 1980.

    PubMed  CAS  Google Scholar 

  89. Courtneidge, S.A., Levinson, A.D., and Bishop, J.M. The protein encoded by the transforming gene of avian sarcoma virus (Pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane. Proc. Natl. Acad. Sci. USA, 77:7:3783, 1980.

    PubMed  CAS  Google Scholar 

  90. Spector, M., O’Neal, S., and Racker, E. Phosphorylation of the subunit of Na+K+-ATPase in Ehrlich ascites tumor by a membrane-bound protein kinase. J. Biol. Chem. 255:18: 8370, 1980.

    PubMed  CAS  Google Scholar 

  91. Senger, D.R., Wirth, D.F., and Hynes, R.O. Transformation-specific secreted phosphoproteins. Nature, 286:619, 1980.

    PubMed  CAS  Google Scholar 

  92. Sharp, P.A. Summary: molecular biology of viral oncogenes. Cold Spring Harbor Sympos. Quant Biol., 44:130 5, 1980.

    Google Scholar 

  93. Newmark, P. Tyrosine phosphorylation and oncogenes. Nature, 292:15, 1981.

    PubMed  CAS  Google Scholar 

  94. Spector, M., Pepinsky, R.B., Vogt, V.M., and Racker, E. A mouse homolog to the Avian sarcoma virus src protein is a member of a protein kinase cascade. Cell., 25:9, 1981.

    PubMed  CAS  Google Scholar 

  95. Nonoyama, M., Casareale, D., Tanaka, A., and Smith, M. Macromolecular events during blastogenic transformation of B-lymphocytes with Epstein-Barr virus. In: IVth Internat1. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  96. Pagano, J.S., Raab-Traub, N., Fleighny, R. and Pearson, G. EBV expression in nasopharyngeal carcinoma. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  97. Fraenkel-Conrat, H. RNA polymerase from tobacco necrosis virus infected and uninfected tobacco. Purification of the membrane-associated enzyme. Virology, 72:23, 1976.

    PubMed  CAS  Google Scholar 

  98. LeRoy, C., Stussi-Garaud, C., and Hirth, L. RNA-dependent RNA polymerase in uninfected and in Alfalfa Mosaic virus-infected tobacco plants. Virology, 82:48, 1977.

    CAS  Google Scholar 

  99. Downey, K.M., Byrnes, J.J., Jurmark, B.S., and So, A.G. Reticulocyte RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA, 70:12:3400, 1973.

    PubMed  CAS  Google Scholar 

  100. Todaro, G.J., Fryling, C.H., and deLarco, J.E. Transforming growth factors produced by certain human tumor cells; polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA, 77:9:5258, 1980.

    PubMed  CAS  Google Scholar 

  101. Roberts, A.B., Lamb, L.C., Newton, D.L., Sporn, M.B., deLarco, J.E., and Todaro, G.J. Transforming growth factors; isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl. Acad. Sci. USA, 77:6:3494, 1980.

    PubMed  CAS  Google Scholar 

  102. Epstein, M.A. and Achong, B.G. Introduction: discovery and general biology of the virus. In; M.A. Epstein and B.G. Achong (eds.), The Epstein-Barr Virus. Chapter 1. Berlin-Heidelberg-New York; Springer Verlag, 1979.

    Google Scholar 

  103. University Health Physicians and PHLS Laboratories. Infectious mononucleosis and its relationship to EB virus antibody. Br. J. Med., IV:643, 1971.

    Google Scholar 

  104. Haider, S., Soutino, M.D., and Emond, R.T.D. Tuberculin anergy and infectious mononucleosis. Lancet, ii:74, 1973.

    Google Scholar 

  105. Mangi, R.J., Niederman, J.C., Kelleher, J.E. Jr., Dwyer, J.M., Evans, A.S., and Kanto, F.S. Depression of cell mediated immunity during acute infectious mononucleosis. N. Engl. J. Med., 291;1149, 1974.

    PubMed  CAS  Google Scholar 

  106. Henle, G. and Henle, W. Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma. Bibl. Haematol., 43:322, 1975.

    PubMed  Google Scholar 

  107. Hutt, L.M., Huang, Y.T., Dascomb, H.E., and Pagano, J.S. Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis. J. Immunol., 115:243, 1975.

    PubMed  CAS  Google Scholar 

  108. Royston, I., Sullivan, J.L., Perlman, P.O., and Perlin, E. Cell mediated immunity to Epstein-Barr virus-transformed lymphoblastoid cells in acute infectious mononucleosis. N. Engl. J. Med., 293:1159, 1977.

    Google Scholar 

  109. Svedmyr, E. and Jondal, M. Cytotoxic effector cells specific for B-cell lines transformed by Epstein-Barr virus are present within patients with infectious mononucleosis. Proc. Natl. Acad. Sci. USA, 72:1622, 1975.

    PubMed  CAS  Google Scholar 

  110. Purtilo, D.T., Sakamoto, K., Saemundsen, A.K., Sullivan, J.L., Synnerholm, A.C., Andersson-Anvret, M., Pritchard, J., Sloper, C., Sieff, C., Pincott, J., Pachman, L., Rich, K., Cruzi, F., Cornet, J., Collins, R., Barnes, N., Knight, J., Sandstedt, B., and Klein, G. Documentation of Epstein-Barr virus infection in iramuno-deficient patients with life-threatening lymphoproli-ferative diseases by clinical, virological, and immunopathological studies. Cancer Res., 41:4226, 1981.

    PubMed  CAS  Google Scholar 

  111. Saemundsen, A.K., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Synnerholm, A.C., Hanto, D., Simmons, R., Anvret, M., Collins, R., and Klein, G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res., 41:4237, 1981.

    PubMed  CAS  Google Scholar 

  112. Purtilo, D.T. X-linked lymphoproliferative syndrome: an immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis or malignant lymphoma following infection by Epstein-Barr virus. Arch. Pathol. Lab. Med., 105:119, 1981.

    PubMed  CAS  Google Scholar 

  113. Krueger, G.R.F. and Chan, S.H. Session IVb: non virus- related immunologic data on NPC. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5 pp. 324–325. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  114. Symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients. G. Klein and D.T. Purtilo (eds.), Cancer Res., 41:4209, 1981.

    Google Scholar 

  115. Penn, I. Allograft Transplant Cancer Registry. In: D.T. Purtilo (ed.), Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies. New York: Plenum Press, 1983.

    Google Scholar 

  116. Penn, I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery, 83:492, 1978.

    PubMed  CAS  Google Scholar 

  117. Chen-Chuan, L., Jian-Jing, C., and Wan-Jun, L. Early detection of NPC by mass screening and nasopharyngeal mucosal hyperplastic lesion (NPHL). In: IVth Internatl. Sympos. NPC, Kuala Lumpur, Malaysia, in print, 1982.

    Google Scholar 

  118. de Thé, G., Desgranges, C., Zeng, Y., Wang, P.C., Bornkamm, G.W., Zhu, J.S., and Shang, M. Search for precancerous lesions and EBV markers in the nasopharynx of IgA positive individuals. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5 pp. 111–117. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  119. Ho, J.H., Kwan, H.C., Ng, M.H., and de Thé, G. Serum IgA antibodies to Epstein-Barr viral capsid antigen preceding symptoms of nasopharyngeal carcinoma. Lancet, i:436, 1978.

    Google Scholar 

  120. Jondal, M., Svedmyr, E., and Klein, E. Killer T-cells in a Burkitt’s lymphoma biopsy. Nature, 225:405, 1975.

    Google Scholar 

  121. Klein, E., Svedmyr, E., Jondal, M. and Vanky, F. Functional studies on tumor-infiltrating lymphocytes in man. Isr. J. Med. Sci., 13:747, 1977.

    PubMed  CAS  Google Scholar 

  122. de Schryver, A., Rosen, A., Gunven, P., and Klein, G. Comparison between two antibody populations in the EBV system: anti-MA versus neutralizing antibody activity. Int. J. Cancer, 17: 8, 1976.

    PubMed  Google Scholar 

  123. Levine, P.H., Pizza, G., Cannon, G., Ablashi, D.V., Armstrong, G., and Viza, D. Cell-mediated immunity to Epstein-Barr virus-associated membrane antigens in patients with nasopharyngeal carcinoma. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 137–144. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  124. Nkrumah, F.K., Herberman, R., Biggar, R.M., and Perkins, J.V. Sequential evaluation of cutaneous delayed hypersensitivity responses to recall and lymphoid cell line antigens in Burkitt’s lymphoma. Int. J. Cancer, 20:6, 1977.

    PubMed  CAS  Google Scholar 

  125. Levine, P.H., Ho, J.H.C., Nkrumah, F.K., Perlman, P., Mauroli, N., Cannon, G., Middleton, M.B., Perkins, J.V., and Herberman, R. Delayed hypersensitivity reactions of cancer patients to antigens of lymphoid cell lines. Int. J. Cancer, 22:400, 1978.

    PubMed  CAS  Google Scholar 

  126. Levine, P.H., de Thé, G., Brugere, J., Schwaab, G., Mouroli, N., Herberman, R.B., Ambrosioni, J.C., and Rebol, P. Immunity to antigens associated with a cell line derived from nasopharyngeal cancer (NPC) in on-Chinese NPC patients. Int. J. Cancer, 17:155, 1976.

    PubMed  CAS  Google Scholar 

  127. Pope, J.H. Specificity of the cytotoxic T-cell response to EBV virus in vitro. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  128. Chan, S.H., Chew, T.S., Goh, E.H., Simons, M.J., and Shanmugaratnam, K. Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma. Int. J. Cancer, 18:139, 1976.

    PubMed  CAS  Google Scholar 

  129. Sesterhenn, K., Bertram, G., and Wustrow, F. Skin testing in NPC patients. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 179–191. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  130. Bertram, G., Pearson, G.R., Faggioni, A. et al. Long-term survey of EBV-serology and non-EBV related tests in correlation to the clinical course. In: IVth Internatl. Sympos. NPC. Kuala Lumpur, Malaysia, 1982; in print.

    Google Scholar 

  131. Micheau, C., de Thé, G., Orofiamma, B., Schwaab, G., Brugere, J., Tursz, T., Sancho-Garnier, H., and Cachin, Y. Practical value of classifying NPC in two major microscopical types. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 51–57. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  132. Ho, J.H.C. Stage classification of nasopharyngeal carcinoma: a review. In: G. de The and Y. Ito (eds.), IARC Scientific Publ. Vol. 20, pp. 99–113. Lyon: IARC, 1978.

    Google Scholar 

  133. de Thé, G., Ho, J.H.C., Ablashi, D.V., Day, N.E., Macario, A.J.L., Martin-Berthelson, M.C;., Pearson, G., and Sohier, R. Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patients. Int. J. Cancer, 16:713, 1974.

    Google Scholar 

  134. Wustrow, J., Karpinski, A., Haas, W., Krueger, G.R.F., Bertram, G., and Sesterhenn, K. Correlation of histological NPC tumor types with local and peripheral T- and B-cell values. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 193–199. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  135. Desgranges, C., Li, J.Y., and de Thé, G. EBV-specific secretory IgA saliva of MPC patients. Presence of secretory piece in epithelial malignant cells. Int. J. Cancer, 20:881, 1977.

    PubMed  CAS  Google Scholar 

  136. Pearson, G.R., Weiland, L.F., Neel III, H. G. Taylor, W., Goepfert, H., Huang, A. Hyams, V. Lanier, A. Levine, L. Pilch, B. Henle, G., and Henle, W. Evaluation of antibodies to the Epstein-Barr virus (EBV) in the diagnosis of American nasopharyngeal carcinoma. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (eds.), Nasopharyngeal Carcinoma. Cancer Campaign. Vol. 5, pp. 231–236. New York: Gustav Fischer Verlag-Stuttgart, 1981.

    Google Scholar 

  137. Pearson, G.R., Johansson, B., and Klein, G. Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma. Int. J. Cancer, 22:120, 1978.

    PubMed  CAS  Google Scholar 

  138. Chan, S.H., Levine, P.H., de The, G., Mulroney, S.E., Lauoue, M.F., Glen, S.P.P., Goh, E.H., Khor, T.H., and Connelly, R.R. A comparison of the prognostic values of antibody-dependent lymphocyte cytotoxicity and other EBV antibody assays in Chinese patients with nasopharyngeal carcinoma. Int. J. Cancer, 23:181, 1979.

    PubMed  CAS  Google Scholar 

  139. Bertram, G., Pearson, G.R., Faggioni, A., Armstrong, G., Krueger, G.R.F., and Ablashi, D.V. The nasopharyngeal carcinoma (NPC): prognostic estimation of antibody-dependent-cellular-cytotoxicity (ADCC). Arch. Otorhinolaryngol., 231:768, 1981.

    Google Scholar 

  140. Sundar, K.S., Ablashi, D.V., Kamaraju, L.S., Levine, P.H., Fagguni, A., Armstrong, G.R., Pearson, G.R., Krueger, G.R.F., Hewetson, J.F., Bertram, G., Sesterhenn, K., and Menezes, J. Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocytes responses. Int. J. Cancer, 29:407, 1982.

    PubMed  CAS  Google Scholar 

  141. Heimer, R. and Klein, G. Circulating immune complexes in sera of patients with Burkitt’s lymphoma and nasopharyngeal carcinoma. Int. J. Cancer, 18:310, 1976.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunopathology Section, Pathology Institute, University of Cologne, 5000, Cologne 41, Federal Republic of Germany

    Gerhard R. F. Krueger

Authors
  1. Gerhard R. F. Krueger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Nebraska Medical Center, Omaha, Nebraska, USA

    David T. Purtilo

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Publishing Corporation

About this chapter

Cite this chapter

Krueger, G.R.F. (1984). Nasopharyngeal Carcinoma. In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4760-6_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4762-0

  • Online ISBN: 978-1-4684-4760-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation